Explore the transformative potential of non-invasive, non-pharmacological therapies for chronic pain management, as discussed in the insightful commentary on Ikarashi et al.’s research.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Analyzing the Clinical Potential of Stromal Vascular Fraction: A Comprehensive Literature Review.
Goncharov et al., Medicina (Kaunas) 2024
<!– DOI: 10.3390/medicina60020221 //–>
https://doi.org/10.3390/medicina60020221
Background: The stromal vascular fraction (SVF) from adipose tissue, known for its diverse cell composition, has emerged as a promising therapeutic tool in regenerative medicine. Its discovery traces back to fat cell metabolism studies in the 1960s, with its multipotency and therapeutic potential recognized later. SVF includes cells like pericytes, smooth muscle cells, and notably, adipose-derived stem cells (ADSCs), which contribute to tissue regeneration and repair through differentiation and growth factor secretion.
Methods: This review synthesizes information on SVF’s composition, mechanisms of action, clinical applications, and future directions, based on a literature search from January 2018 to June 2023 across databases such as PubMed and Embase.
Results: Out of 473 articles identified, 16 met the inclusion criteria for the review, providing a comprehensive overview of SVF’s role in regenerative medicine.
Conclusions: SVF has shown promise across various medical disciplines, offering therapeutic benefits like improved pain management, tissue regeneration, graft survival, and wound healing, alongside immunomodulatory and anti-inflammatory effects. This review underscores SVF’s potential as a significant contributor to the field of regenerative medicine.